BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rao CV, Mohammed A. New insights into pancreatic cancer stem cells. World J Stem Cells 2015; 7(3): 547-555 [PMID: 25914762 DOI: 10.4252/wjsc.v7.i3.547]
URL: https://www.wjgnet.com/1948-0210/full/v7/i3/547.htm
Number Citing Articles
1
Seyed Alireza Javadinia, Soodabeh Shahidsales, Azar Fanipakdel, Mona Joudi‐Mashhad, Mehrane Mehramiz, Sahar Talebian, Mona Maftouh, Ramin Mardani, Seyed Mahdi Hassanian, Majid Khazaei, Gordon A. Ferns, Amir Avan. Therapeutic potential of targeting the Wnt/β‐catenin pathway in the treatment of pancreatic cancerJournal of Cellular Biochemistry 2019; 120(5): 6833 doi: 10.1002/jcb.27835
2
Jheelam Banerjee, Arokya M.S. Papu John, Mohammed H. Al-Wadei, Hildegard M. Schuller. Prevention of pancreatic cancer in a hamster model by cAMP decreaseOncotarget 2016; 7(28): 44430 doi: 10.18632/oncotarget.9790
3
Fang Huang, Bin-Rong Wang, Ye-Qing Wu, Fan-Chao Wang, Jian Zhang, Yi-Gang Wang. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancerWorld Journal of Gastroenterology 2016; 22(35): 7999-8009 doi: 10.3748/wjg.v22.i35.7999
4
Geou-Yarh Liou. CD133 as a regulator of cancer metastasis through the cancer stem cellsThe International Journal of Biochemistry & Cell Biology 2019; 106: 1 doi: 10.1016/j.biocel.2018.10.013
5
Jingchang Zhang, Renfeng Li, Shuai Huang. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.951019
6
Toshiyuki Ishiwata, Yoko Matsuda, Hisashi Yoshimura, Norihiko Sasaki, Shunji Ishiwata, Naoshi Ishikawa, Kaiyo Takubo, Tomio Arai, Junko Aida. Pancreatic cancer stem cells: features and detection methodsPathology & Oncology Research 2018; 24(4): 797 doi: 10.1007/s12253-018-0420-x
7
Kalyani Patil, Farheen B. Khan, Sabah Akhtar, Aamir Ahmad, Shahab Uddin. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistanceCancer and Metastasis Reviews 2021; 40(3): 691 doi: 10.1007/s10555-021-09979-x
8
Mustafa Hoca, Eda Becer, Hilal Kabadayı, Sevinç Yücecan, Hafize Seda Vatansever. The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem CellNutrition and Cancer 2020; 72(7): 1231 doi: 10.1080/01635581.2019.1670853
9
Shirin Eyvazi, Bahram Kazemi, Mojgan Bandehpour, Siavoush Dastmalchi. Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cellsImmunology Letters 2017; 190: 240 doi: 10.1016/j.imlet.2017.08.028
10
Rui Gradiz, Henriqueta C. Silva, Lina Carvalho, Maria Filomena Botelho, Anabela Mota-Pinto. MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptorsScientific Reports 2016; 6(1) doi: 10.1038/srep21648
11
Kostas Palamaris, Evangelos Felekouras, Stratigoula Sakellariou. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and ChemoresistanceCancers 2021; 13(21): 5532 doi: 10.3390/cancers13215532
12
Satish Sagar, Christabelle Rajesh, Prakash Radhakrishnan. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects2022; : 1 doi: 10.1007/978-981-16-1247-3_95-1
13
Sepideh Ghani, Shirin Eyvazi, Zahra Ebrahimi, Mojgan Bandehpour. In Silico Evaluation of the Interactions Among Novel Phage Display-Selected Single Chain Variable Fragment (scFv) with CD24 MarkerInternational Journal of Cancer Management 2023; (In Press) doi: 10.5812/ijcm-136917
14
Matthew Hadden, Anubhav Mittal, Jaswinder Samra, Hala Zreiqat, Sumit Sahni, Yogambha Ramaswamy. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188418 doi: 10.1016/j.bbcan.2020.188418
15
Jiangang Zhao, Jiahui Li, Hans A. Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl-Walter Jauch, Christiane J. Bruns, Yue Zhao. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic CancerStem Cells International 2017; 2017: 1 doi: 10.1155/2017/6012810
16
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesWorld Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
17
Motofumi Kumazoe, Mika Takai, Shun Hiroi, Chieri Takeuchi, Maasa Yamanouchi, Takashi Nojiri, Hiroaki Onda, Jaehoon Bae, Yuhui Huang, Kanako Takamatsu, Shuya Yamashita, Shuhei Yamada, Kenji Kangawa, Takashi Takahashi, Hiroshi Tanaka, Hirofumi Tachibana. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02162-9
18
Gitika Thakur, Raj Kumar, Saet-Byul Kim, Sang-Yeob Lee, Sung-Lim Lee, Gyu-Jin Rho. Therapeutic Status and Available Strategies in Pancreatic Ductal AdenocarcinomaBiomedicines 2021; 9(2): 178 doi: 10.3390/biomedicines9020178
19
Rowa Bakadlag, Pouria Jandaghi, Jörg D. Hoheisel, Yasser Riazalhosseini. The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancerExpert Opinion on Therapeutic Targets 2019; 23(5): 365 doi: 10.1080/14728222.2019.1606904
20
Tara L. Hogenson, Hao Xie, William J. Phillips, Merih D. Toruner, Jenny J. Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan M. Carr, Murat Toruner, Ashley N. Sigafoos, Amanda N. Koenig-Kappes, Rachel L.O. Olson, Ezequiel J. Tolosa, Cheng Zhang, Hu Li, Jason D. Doles, Jonathan Bleeker, Michael T. Barrett, James H. Boyum, Benjamin R. Kipp, Amit Mahipal, Joleen M. Hubbard, Temperance J. Scheffler Hanson, Gloria M. Petersen, Surendra Dasari, Ann L. Oberg, Mark J. Truty, Rondell P. Graham, Michael J. Levy, Mojun Zhu, Daniel D. Billadeau, Alex A. Adjei, Nelson Dusetti, Juan L. Iovanna, Tanios S. Bekaii-Saab, Wen Wee Ma, Martin E. Fernandez-Zapico. Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancersJCI Insight 2022; 7(22) doi: 10.1172/jci.insight.158060
21
Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva. Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer TherapiesMarine Drugs 2022; 20(11): 689 doi: 10.3390/md20110689
22
Vahideh Tarhriz, Mojgan Bandehpour, Siavoush Dastmalchi, Elaheh Ouladsahebmadarek, Habib Zarredar, Shirin Eyvazi. Overview of CD24 as a new molecular marker in ovarian cancerJournal of Cellular Physiology 2019; 234(3): 2134 doi: 10.1002/jcp.27581
23
Astrid Belalcazar, Ganji Purnachandra Nagaraju. Theranostic Approach for Pancreatic Cancer2019; : 69 doi: 10.1016/B978-0-12-819457-7.00003-7
24
Zhongbo Zhang, Yuanhong Xu, Chenghai Zhao. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancerCancer Medicine 2021; 10(10): 3332 doi: 10.1002/cam4.3819
25
Xiaoya Wan, Daiyuan Ma, Guanglin Song, Lina Tang, Xianxue Jiang, Yingguo Tian, Zunli Yi, Chengying Jiang, Yong Jin, Anmu Hu, Yuju Bai. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cellsJournal of Bioenergetics and Biomembranes 2024; 56(3): 323 doi: 10.1007/s10863-024-10009-y
26
James T. Oswald, Haritosh Patel, Daid Khan, Ninweh N. Jeorje, Hossein Golzar, Erin L. Oswald, Shirley Tang. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem CellsCurrent Pharmaceutical Design 2020; 26(17): 2057 doi: 10.2174/1381612826666200406084900
27
Emilie A. G. Molins, William J. Jusko. Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer CellsThe AAPS Journal 2018; 20(5) doi: 10.1208/s12248-018-0235-4
28
Faezeh Ghasemi, Parisa Zia Sarabi, Seyyed Shamsadin Athari, Abdolreza Esmaeilzadeh. Therapeutics strategies against cancer stem cell in breast cancerThe International Journal of Biochemistry & Cell Biology 2019; 109: 76 doi: 10.1016/j.biocel.2019.01.015
29
Claudia Di Carlo, Jessica Brandi, Daniela Cecconi. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinomaWorld Journal of Stem Cells 2018; 10(11): 172-182 doi: 10.4252/wjsc.v10.i11.172
30
Jonas Schnittert, Ruchi Bansal, Jai Prakash. Targeting Pancreatic Stellate Cells in CancerTrends in Cancer 2019; 5(2): 128 doi: 10.1016/j.trecan.2019.01.001
31
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer ProgressionFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
32
Satish Sagar, Christabelle Rajesh, Prakash Radhakrishnan. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects2022; : 2021 doi: 10.1007/978-981-16-5422-0_95
33
Gaurav Kumar, Mudassir Farooqui, Chinthalapally V. Rao. Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem CellsCurrent Pharmacology Reports 2018; 4(4): 326 doi: 10.1007/s40495-018-0145-2
34
Batoul Farran, Ganji Purnachandra Nagaraju. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targetsCytokine & Growth Factor Reviews 2019; 48: 11 doi: 10.1016/j.cytogfr.2019.07.001
35
Zhongbo Zhang, Yuanhong Xu. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signalingMolecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00509-1
36
Begum Dariya, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostic Approach for Pancreatic Cancer2019; : 1 doi: 10.1016/B978-0-12-819457-7.00001-3
37
Taylor J. Allen-Coyle, Jin Niu, Eva Welsch, Neil T. Conlon, Weylon Garner, Martin Clynes, Finbarr O’Sullivan, Robert M. Straubinger, Donald E. Mager, Sandra Roche. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell CulturesThe AAPS Journal 2022; 24(6) doi: 10.1208/s12248-022-00752-8
38
Rituraj Chakraborty, Anupam Dutta, Bhargab Jyoti Baruah, Rajni Kumari, Priyanku Sarma, Ankita Sharma, Krishangi Goswami, Haritha Myakala, Akalesh Kumar Verma. Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical Treatment and OutcomesCurrent Cancer Therapy Reviews 2024; 20(3): 263 doi: 10.2174/1573394719666230830125213
39
Nikhil Tyagi, Saravanakumar Marimuthu, Arun Bhardwaj, Sachin K. Deshmukh, Sanjeev K. Srivastava, Ajay P. Singh, Steven McClellan, James E. Carter, Seema Singh. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingCancer Letters 2016; 370(2): 260 doi: 10.1016/j.canlet.2015.10.028
40
Hengqiang Zhao, Qingke Duan, Zhengle Zhang, Hehe Li, Heshui Wu, Qiang Shen, Chunyou Wang, Tao Yin. Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cellsJournal of Cellular and Molecular Medicine 2017; 21(9): 2055 doi: 10.1111/jcmm.13126
41
Hao Wu, Jialin Liu, Zhifei Wang, Wen Yuan, Ling Chen. Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastomaCNS Neuroscience & Therapeutics 2021; 27(10): 1105 doi: 10.1111/cns.13714
42
Lianna Li, Hao Mei, Abednego Nii Adom Commey. Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cellsCancer Gene Therapy 2020; 27(9): 691 doi: 10.1038/s41417-019-0144-4
43
Maria Mortoglou, Francesc Miralles, Elif Damla Arisan, Alwyn Dart, Stipo Jurcevic, Sigrun Lange, Pinar Uysal-Onganer. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma CellsInternational Journal of Molecular Sciences 2022; 23(3): 1275 doi: 10.3390/ijms23031275